Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

HIV-1 capsids from B27/B57+ elite controllers escape Mx2 but are targeted by TRIM5α, leading to the induction of an antiviral state.

Merindol N, El-Far M, Sylla M, Masroori N, Dufour C, Li JX, Cherry P, Plourde MB, Tremblay C, Berthoux L.

PLoS Pathog. 2018 Nov 12;14(11):e1007398. doi: 10.1371/journal.ppat.1007398. eCollection 2018 Nov.

2.

Editing of the human TRIM5 gene to introduce mutations with the potential to inhibit HIV-1.

Dufour C, Claudel A, Joubarne N, Merindol N, Maisonnet T, Masroori N, Plourde MB, Berthoux L.

PLoS One. 2018 Jan 26;13(1):e0191709. doi: 10.1371/journal.pone.0191709. eCollection 2018.

3.

Gene Knockout Shows That PML (TRIM19) Does Not Restrict the Early Stages of HIV-1 Infection in Human Cell Lines.

Masroori N, Cherry P, Merindol N, Li JX, Dufour C, Poulain L, Plourde MB, Berthoux L.

mSphere. 2017 Jun 21;2(3). pii: e00233-17. doi: 10.1128/mSphereDirect.00233-17. eCollection 2017 May-Jun.

4.
5.

Restriction Factors in HIV-1 Disease Progression.

Merindol N, Berthoux L.

Curr HIV Res. 2015;13(6):448-61. Review.

PMID:
26051387
6.

Development of an IFN-γ ELISpot assay to assess varicella-zoster virus-specific cell-mediated immunity following umbilical cord blood transplantation.

Salem Fourati I, Grenier AJ, Jolette É, Merindol N, Ovetchkine P, Soudeyns H.

J Vis Exp. 2014 Jul 9;(89). doi: 10.3791/51643.

7.

The emerging role of Twist proteins in hematopoietic cells and hematological malignancies.

Merindol N, Riquet A, Szablewski V, Eliaou JF, Puisieux A, Bonnefoy N.

Blood Cancer J. 2014 Apr 25;4:e206. doi: 10.1038/bcj.2014.22. Review. Erratum in: Blood Cancer J. 2014 Oct;4:e254.

8.

Evolution of HIV-1 coreceptor usage and coreceptor switching during pregnancy.

Ransy DG, Motorina A, Merindol N, Akouamba BS, Samson J, Lie Y, Napolitano LA, Lapointe N, Boucher M, Soudeyns H.

AIDS Res Hum Retroviruses. 2014 Mar;30(3):312-24. doi: 10.1089/AID.2013.0155. Epub 2013 Oct 25. Erratum in: AIDS Res Hum Retroviruses. 2014 May;30(5):509.

9.

Reconstitution of protective immune responses against cytomegalovirus and varicella zoster virus does not require disease development in pediatric recipients of umbilical cord blood transplantation.

Merindol N, Salem Fourati I, Brito RM, Grenier AJ, Charrier E, Cordeiro P, Caty M, Mezziani S, Malette B, Duval M, Alfieri C, Ovetchkine P, Le Deist F, Soudeyns H.

J Immunol. 2012 Nov 15;189(10):5016-28. doi: 10.4049/jimmunol.1201759. Epub 2012 Oct 3.

10.

Post-transcriptional down-regulation of Toll-like receptor signaling pathway in umbilical cord blood plasmacytoid dendritic cells.

Charrier E, Cordeiro P, Cordeau M, Dardari R, Michaud A, Harnois M, Merindol N, Herblot S, Duval M.

Cell Immunol. 2012 Mar-Apr;276(1-2):114-21. doi: 10.1016/j.cellimm.2012.04.010. Epub 2012 Apr 27.

PMID:
22578600
11.

CD8(+) T-cell reconstitution in recipients of umbilical cord blood transplantation and characteristics associated with leukemic relapse.

Merindol N, Champagne MA, Duval M, Soudeyns H.

Blood. 2011 Oct 20;118(16):4480-8. doi: 10.1182/blood-2011-04-349241. Epub 2011 Aug 2.

12.

Complementary and contrasting roles of NK cells and T cells in pediatric umbilical cord blood transplantation.

Merindol N, Charrier E, Duval M, Soudeyns H.

J Leukoc Biol. 2011 Jul;90(1):49-60. doi: 10.1189/jlb.0111007. Epub 2011 Mar 2. Review.

PMID:
21367975
13.

Novel HIV-1 recombinant forms in antenatal cohort, Montreal, Quebec, Canada.

Quesnel-Vallières M, Kouzayha I, Tran E, Barry I, Lasgi C, Merindol N, Monteil V, Ransy DG, Boucher M, Lapointe N, Soudeyns H.

Emerg Infect Dis. 2011 Feb;17(2):271-4. doi: 10.3201/eid1702.100629.

14.

Umbilical cord blood T cells respond against the Melan-A/MART-1 tumor antigen and exhibit reduced alloreactivity as compared with adult blood-derived T cells.

Merindol N, Grenier AJ, Caty M, Charrier E, Duval A, Duval M, Champagne MA, Soudeyns H.

J Immunol. 2010 Jul 15;185(2):856-66. doi: 10.4049/jimmunol.0902613. Epub 2010 Jun 11.

15.

Generation of potent and stable human CD4+ T regulatory cells by activation-independent expression of FOXP3.

Allan SE, Alstad AN, Merindol N, Crellin NK, Amendola M, Bacchetta R, Naldini L, Roncarolo MG, Soudeyns H, Levings MK.

Mol Ther. 2008 Jan;16(1):194-202. Epub 2007 Nov 6.

16.

HIV-1 genetic diversity in antenatal cohort, Canada.

Akouamba BS, Viel J, Charest H, Merindol N, Samson J, Lapointe N, Brenner BG, Lalonde R, Harrigan PR, Boucher M, Soudeyns H.

Emerg Infect Dis. 2005 Aug;11(8):1230-4.

Supplemental Content

Loading ...
Support Center